Non-invasive Bioluminescence Imaging of Myoblast-Mediated Hypoxia-Inducible Factor-1 Alpha Gene Transfer
Olivier Gheysens,Ian Y. Chen,Martin Rodriguez-Porcel,Carmel Chan,Julia Rasooly,Caroline Vaerenberg,Ramasamy Paulmurugan,Juergen K. Willmann,Christophe Deroose,Joseph Wu,Sanjiv S. Gambhir
DOI: https://doi.org/10.1007/s11307-011-0471-9
2011-01-26
Molecular Imaging and Biology
Abstract:PurposeWe tested a novel imaging strategy, in which both the survival of transplanted myoblasts and their therapeutic transgene expression, a recombinant hypoxia-inducible factor-1α (HIF-1α-VP2), can be monitored using firefly luciferase (fluc) and Renilla luciferase (hrl) bioluminescence reporter genes, respectively.ProceduresThe plasmid pUbi-hrl-pUbi-HIF-1α-VP2, which expresses both hrl and HIF-1α-VP2 using two ubiquitin promoters, was characterized in vitro. C2c12 myoblasts stably expressing fluc and transiently transfected with pUbi-hrl-pUbi-HIF-1α-VP2 were injected into the mouse hindlimb. Both hrl and fluc expression were monitored using bioluminescence imaging (BLI).ResultsStrong correlations existed between the expression of hRL and each of HIF-1α-VP2, VEGF, and PlGF (r2 > 0.83, r2 > 0.82, and r2 > 0.97, respectively). In vivo, both transplanted cells and HIF-1α-VP2 transgene expression were successfully imaged using BLI.ConclusionsAn objective evaluation of myoblast-mediated gene transfer in living mice can be performed by monitoring both the survival and the transgene expression of transplanted myoblasts using the techniques developed herein.
radiology, nuclear medicine & medical imaging